Health officials in the United States have been put under the spotlight today for their seemingly tacit endorsement of biological men “chestfeeding” without adequately discussing the potential health risks that might affect infants.

“Chestfeeding” is a term that trans and non-binary individuals use to describe breastfeeding which would be completely natural for a biological female, and is actually being encouraged by the Centers for Disease Control and Prevention (CDC).

This stance is subtly indicated on several sections of the CDC website.

One such section, called “Health Equity Considerations,” posits that “an individual does not need to have given birth to breastfeed or chestfeed.”

Another, in a Q&A format about breast surgery, addresses the question: “Can transgender parents who have had breast surgery breastfeed or chestfeed their infants?” and suggests that families might need assistance with “medication to induce lactation.”

However, medical professionals have voiced their concerns. Speaking to DailyMail.com, these experts stressed the CDC’s “responsibility” to bring to light the minimal research and potential risks associated with these practices.

Among their chief concerns is the fact that one medication used to produce milk in biological men is linked to heart problems in infants which doesn’t receive enough attention.

RELATED: Glamour Magazine Cover Sparks Outrage: Features Pregnant Transgender Man

Dr. Jane Orient, Executive Director of the Association of American Physicians and Surgeons, told DailyMail.com, “we have no idea what the long-term effects on the child will be” when a breastfeeding trans woman uses “all kinds of off-label hormones.”

She added, “A lot of people are pushing for off-label use of a drug… it’s become so politicized that you can do all kinds of things for a politically approved purpose.”

Dr. Orient concluded by stating, “The CDC has a responsibility to talk about the health risks, but they have been derelict in doing that.”

To stimulate lactation, trans women often turn to a combination of treatments known as the Newman-Goldfarb protocol.

This protocol, originally intended for biological women who wished to breastfeed after adopting or carrying a child via surrogacy, includes using a contraceptive pill to boost estrogen levels, physical stimulation through a breast pump, and the drug domperidone to simulate the hormonal changes seen in late pregnancy and childbirth.

However, potential risks are associated with this protocol. For example, domperidone can sometimes pass into breast milk in small amounts and, as a result, cause irregular heartbeats in infants.

The FDA has expressed its concerns about this and recommends against breastfeeding women using domperidone to increase milk production due to potential serious adverse effects.

Dr. Stuart Fischer, an internal medicine physician in New York, also voiced his concern, expressing skepticism that breast milk produced by biological men could be compared to that produced by biological women.

He stated, “Because it’s induced. You can’t fool Mother Nature.”

He elaborated, indicating there is little research in this area, and said, “If it’s been tested a handful of times, how would we know the long-range effect? The short-term is one thing, but the long-term in terms of physical and mental illness… who knows?”

“It’s an emerging field, to put it mildly.” Dr. Fischer concluded his observations by adding, “This is the kind of thing where politics and science are uncomfortably put together.”

Guidelines advocating such practices were last reviewed on the CDC’s “Infant and Young Child Feeding in Emergencies (IYCF-E) Toolkit” in September 2022. Another related page offering tips for mothers who have undergone breast surgery was updated more recently, in April 2023.

Critics argue that these guidelines blur the boundaries between ‘politics and science’ and express concern that promoting health equity should not disregard potential health risks, particularly when they might affect the health of infants, who are among our most vulnerable population.

This situation has led critics to question the CDC’s responsibility in providing comprehensive health information. They urge that all potential health risks be properly addressed, especially considering the little amount research on the long-term effects of induced lactation in trans women and the usage of certain medication in these processes.

The CDC appears to be advocating for the use of medication that has not been fully vetted in it’s efficacy and safety for the sake of the woke political agenda.

RELATED: Offensive New Term for ‘Vagina’ Has Been Issued to Avoid ‘Distressing’ Trans Patients Who Lack Them